| Literature DB >> 30799070 |
Diego Segala1, Stefano Gobbo1, Anna Pesci2, Guido Martignoni2, Angela Santoro3, Giuseppe Angelico3, Damiano Arciuolo3, Saveria Spadola3, Michele Valente4, Giovanni Scambia5, Gian Franco Zannoni6.
Abstract
It is well known that a large number of patients treated with Tamoxifen develops endometrial pathologies ranging from benign endometrial polyps and hyperplasia to adenocarcinomas, carcinosarcomas and adenosarcomas. UTROSCT (Uterine Tumor Resembling Ovarian Sex Cord Tumor) is defined as a mesenchymal tumors of the uterine corpus that morphologically resembles ovarian sex cord tumors, without recognizable endometrial stroma. To date only 4 cases have been reported in patients treated with tamoxifen. In this article, we describe an additional case occurring in a 62-years-old patient undergoing 3 years of Tamoxifen therapy for bilateral breast carcinoma. The present work represents a further evidence of the possible association between Tamoxifen therapy and UTROSCT. A comprehensive literature review on this topic is also provided.Entities:
Keywords: Breast cancer; Imunohistochemistry; Tamoxifen; UTROSCT; Uterine tumor resembling ovarian sex cord tumor
Mesh:
Substances:
Year: 2019 PMID: 30799070 DOI: 10.1016/j.prp.2019.01.039
Source DB: PubMed Journal: Pathol Res Pract ISSN: 0344-0338 Impact factor: 3.250